Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Phosphofructokinases Axis Controls Glucose-Dependent mTORC1 Activation Driven by E2F1.

  • Almacellas i Canals, Eugènia
  • Pelletier, Joffrey
  • Manzano Cuesta, Anna
  • Gentilella, Antonio
  • Ambrosio Viale, Santiago
  • Mauvezin, Caroline
  • Tauler Girona, Albert
Cancer cells rely on mTORC1 activity to coordinate mitogenic signaling with nutrients availability for growth. Based on the metabolic function of E2F1, we hypothesize that glucose catabolism driven by E2F1 could participate on mTORC1 activation. Here, we demonstrate that glucose potentiates E2F1-induced mTORC1 activation by promoting mTORC1 translocation to lysosomes, a process that occurs independently of AMPK activation. We showed that E2F1 regulates glucose metabolism by increasing aerobic glycolysis and identified the PFKFB3 regulatory enzyme as an E2F1-regulated gene important for mTORC1 activation. Furthermore, PFKFB3 and PFK1 were found associated to lysosomes and we demonstrated that modulation of PFKFB3 activity, either by substrate accessibility or expression, regulates the translocation of mTORC1 to lysosomes by direct interaction with Rag B and subsequent mTORC1 activity. Our results support a model whereby a glycolytic metabolon containing phosphofructokinases transiently interacts with the lysosome acting as a sensor platform for glucose catabolism toward mTORC1 activity.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Nucleotide depletion reveals the impaired ribosomebiogenesis checkpoint as a barrier against DNA damage

  • Pelletier, Joffrey
  • Riaño Canalias, Ferran
  • Almacellas i Canals, Eugènia
  • Mauvezin, Caroline
  • Samino Gené, Sara
  • Feu i Coll, Sònia
  • Menoyo, Sandra
  • Domostegui Fernández, Ana
  • García Cajide, Marta
  • Salazar Soler, Ramón
  • Cortés, Constanza
  • Marcos, Ricard
  • Tauler Girona, Albert
  • Yanes, Oscar
  • Agell i Jané, Neus
  • Kozma, Sara C.
  • Gentilella, Antonio
  • Thomas, George
Many oncogenes enhance nucleotide usage to increase ribosome content, DNA replication, and cell proliferation, but in parallel trigger p53 activation. Both the impaired ribosome biogenesis checkpoint (IRBC) and the DNA damage response (DDR) have been implicated in p53 activation following nucleotide depletion. However, it is difficult to reconcile the two checkpoints operating together, as the IRBC induces p21‐mediated G1 arrest, whereas the DDR requires that cells enter S phase. Gradual inhibition of inosine monophosphate dehydrogenase (IMPDH), an enzyme required for de novo GMP synthesis, reveals a hierarchical organization of these two checkpoints. We find that the IRBC is the primary nucleotide sensor, but increased IMPDH inhibition leads to p21 degradation, compromising IRBC‐mediated G1 arrest and allowing S phase entry and DDR activation. Disruption of the IRBC alone is sufficient to elicit the DDR, which is strongly enhanced by IMPDH inhibition, suggesting that the IRBC acts as a barrier against genomic instability.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Lysosomal degradation ensures accurate chromosomal segregation to prevent chromosomal instability

  • Almacellas i Canals, Eugènia
  • Pelletier, Joffrey
  • Day, Charles
  • Ambrosio Viale, Santiago
  • Tauler Girona, Albert
  • Mauvezin, Caroline
Lysosomes, as primary degradative organelles, are the end-point of different converging pathways including macroautophagy. To date, lysosome degradative function has been mainly studied in interphase cells, while their role during mitosis remains controversial. Mitosis dictates the faithful transmission of genetic material among generations, and perturbations of mitotic division lead to chromosomal instability, a hallmark of cancer. Heretofore, correct mitotic progression relies on the orchestrated degradation of mitotic factors, which was mainly attributed to ubiquitin-triggered proteasome-dependent degradation. Here, we show that mitotic transition does not only rely on proteasome-dependent degradation, as impairment of lysosomes increases mitotic timing and leads to mitotic errors, thus promoting chromosomal instability. Furthermore, we identified several putative lysosomal targets in mitotic cells. Among them, WAPL, a cohesin regulatory protein, emerged as a novel SQSTM1-interacting protein for targeted lysosomal degradation. Finally, we characterized an atypical nuclear phenotype, the toroidal nucleus, as a novel biomarker for genotoxic screenings. Our results establish lysosome-dependent degradation as an essential event to prevent chromosomal instability.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Nucleotide depletion reveals the impaired ribosomebiogenesis checkpoint as a barrier against DNA damage

  • Pelletier, Joffrey
  • Riaño Canalias, Ferran
  • Almacellas i Canals, Eugènia
  • Mauvezin, Caroline
  • Samino Gené, Sara
  • Feu i Coll, Sònia
  • Menoyo, Sandra
  • Domostegui Fernández, Ana
  • García Cajide, Marta
  • Salazar Soler, Ramón
  • Cortés, Constanza
  • Marcos, Ricard
  • Tauler Girona, Albert
  • Yanes, Oscar
  • Agell i Jané, Neus
  • Kozma, Sara C.
  • Gentilella, Antonio
  • Thomas, George
Many oncogenes enhance nucleotide usage to increase ribosome content, DNA replication, and cell proliferation, but in parallel trigger p53 activation. Both the impaired ribosome biogenesis checkpoint (IRBC) and the DNA damage response (DDR) have been implicated in p53 activation following nucleotide depletion. However, it is difficult to reconcile the two checkpoints operating together, as the IRBC induces p21‐mediated G1 arrest, whereas the DDR requires that cells enter S phase. Gradual inhibition of inosine monophosphate dehydrogenase (IMPDH), an enzyme required for de novo GMP synthesis, reveals a hierarchical organization of these two checkpoints. We find that the IRBC is the primary nucleotide sensor, but increased IMPDH inhibition leads to p21 degradation, compromising IRBC‐mediated G1 arrest and allowing S phase entry and DDR activation. Disruption of the IRBC alone is sufficient to elicit the DDR, which is strongly enhanced by IMPDH inhibition, suggesting that the IRBC acts as a barrier against genomic instability.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Phosphofructokinases Axis Controls Glucose-Dependent mTORC1 Activation Driven by E2F1.

  • Almacellas i Canals, Eugènia
  • Pelletier, Joffrey
  • Manzano Cuesta, Anna
  • Gentilella, Antonio
  • Ambrosio Viale, Santiago
  • Mauvezin, Caroline
  • Tauler Girona, Albert
Cancer cells rely on mTORC1 activity to coordinate mitogenic signaling with nutrients availability for growth. Based on the metabolic function of E2F1, we hypothesize that glucose catabolism driven by E2F1 could participate on mTORC1 activation. Here, we demonstrate that glucose potentiates E2F1-induced mTORC1 activation by promoting mTORC1 translocation to lysosomes, a process that occurs independently of AMPK activation. We showed that E2F1 regulates glucose metabolism by increasing aerobic glycolysis and identified the PFKFB3 regulatory enzyme as an E2F1-regulated gene important for mTORC1 activation. Furthermore, PFKFB3 and PFK1 were found associated to lysosomes and we demonstrated that modulation of PFKFB3 activity, either by substrate accessibility or expression, regulates the translocation of mTORC1 to lysosomes by direct interaction with Rag B and subsequent mTORC1 activity. Our results support a model whereby a glycolytic metabolon containing phosphofructokinases transiently interacts with the lysosome acting as a sensor platform for glucose catabolism toward mTORC1 activity.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Lysosomal degradation ensures accurate chromosomal segregation to prevent chromosomal instability

  • Almacellas i Canals, Eugènia
  • Pelletier, Joffrey
  • Day, Charles
  • Ambrosio Viale, Santiago
  • Tauler Girona, Albert
  • Mauvezin, Caroline
Lysosomes, as primary degradative organelles, are the end-point of different converging pathways including macroautophagy. To date, lysosome degradative function has been mainly studied in interphase cells, while their role during mitosis remains controversial. Mitosis dictates the faithful transmission of genetic material among generations, and perturbations of mitotic division lead to chromosomal instability, a hallmark of cancer. Heretofore, correct mitotic progression relies on the orchestrated degradation of mitotic factors, which was mainly attributed to ubiquitin-triggered proteasome-dependent degradation. Here, we show that mitotic transition does not only rely on proteasome-dependent degradation, as impairment of lysosomes increases mitotic timing and leads to mitotic errors, thus promoting chromosomal instability. Furthermore, we identified several putative lysosomal targets in mitotic cells. Among them, WAPL, a cohesin regulatory protein, emerged as a novel SQSTM1-interacting protein for targeted lysosomal degradation. Finally, we characterized an atypical nuclear phenotype, the toroidal nucleus, as a novel biomarker for genotoxic screenings. Our results establish lysosome-dependent degradation as an essential event to prevent chromosomal instability.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Nucleotide depletion reveals the impaired ribosome biogenesis checkpoint as a barrier against damage

  • Pelletier, Joffrey|||0000-0001-9174-044X
  • Riaño-Canalias, Ferran
  • Almacellas, Eugènia|||0000-0002-7726-8430
  • Mauvezin, Caroline|||0000-0003-4220-7272
  • Samino, Sara
  • Feu, Sonia
  • Menoyo, Sandra
  • Domostegui, Ana
  • Garcia-Cajide, Marta
  • Salazar, Ramón
  • Cortes Crignola, Constanza|||0000-0001-7254-9607
  • Marcos, Ricard|||0000-0001-7891-357X
  • Tauler, Albert
  • Yanes, Oscar|||0000-0003-3695-7157
  • Agell, Neus|||0000-0002-1205-6074
  • Kozma, Sara C.
  • Gentilella, Antonio|||0000-0002-6830-2086
  • Thomas, George|||0000-0002-1236-1714
Many oncogenes enhance nucleotide usage to increase ribosome content, replication, and cell proliferation, but in parallel trigger p53 activation. Both the impaired ribosome biogenesis checkpoint () and the damage response () have been implicated in p53 activation following nucleotide depletion. However, it is difficult to reconcile the two checkpoints operating together, as the induces p21-mediated G1 arrest, whereas the requires that cells enter S phase. Gradual inhibition of inosine monophosphate dehydrogenase (), an enzyme required for de novo synthesis, reveals a hierarchical organization of these two checkpoints. We find that the is the primary nucleotide sensor, but increased inhibition leads to p21 degradation, compromising -mediated G1 arrest and allowing S phase entry and activation. Disruption of the alone is sufficient to elicit the , which is strongly enhanced by inhibition, suggesting that the acts as a barrier against genomic instability. Hierarchical organization of p21-mediated G1 arrest and S-phase damage response signaling ensures genomic stability upon increasing inhibition of nucleotide synthesis enzyme.